30 closest matches · ranked by relevance
Hyperlipidemia · Hypertension · Diabetes
Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103
Diabetes Mellitus · Hypertension · Hyperlipidemia
Primary: Percent of Participants With Adherence at Month 6 — 91; 40 percent persistent on therapy — p=<0.05
Medication Adherence · Self Efficacy
Primary: Change in Medication Adherence as Measured by the Adherence to Refills and Medications Scale (ARMS) — -4.0; -1.0 score on a scale
Rheumatic Diseases · Gout · Adherence, Medication
Primary: Rate of Medication Adherence — 0.76; 0.79; 0.83 percentage of doses taken — p=0.78
Medication Adherence
Primary: Medication Adherence — 88.1; 96.6; 94.4 percentage of doses taken (pill count)
Hypertension · Medication Adherence
Primary: Electronically Measured Mean Medication Adherence During Intervention — 87; 95; 92 Percentage of Timely Med Adherence
Chronic Rheumatic Diseases
Primary: Intervention Feasibility as Measured by Number of Providers Agreeing to Participate — 6 Participants
Schizophrenia
Primary: Antipsychotic Medication Adherence — 63.9; 75.0 percentage of participants — p=0.03
Adherence, Medication · Nonadherence, Medication
Primary: Median Proportion of Days Covered (PDC) at 8-months Post-enrollment — 0.94; 0.88 proportion of days covered (PDC) — p=0.001
Epilepsy
Primary: Raw Count of Number of Days of Medication Nonadherence — 28 % of nonadherence days
Chronic Disease · Medication Adherence
Primary: Medication Adherence at 1 Month — 11.83; 10.20; 9.33 score on a scale
Hypertension
Primary: Feasibility of Retaining Study Participants Through the 3 Month Trial — 20; 21 Participants
Hypertension · Diabetes · Hypercholesterolemia
Primary: Medication Possession Ratio at Baseline — 65.0 percentage of medication possession
Heart Failure
Primary: Adherence to Medication — 2; 3 Participants
Heart Failure
Primary: Feasibility of AMDD to Improve Medication Adherence Via Completion Rate — 15 participants
Medication Adherence
Primary: Medication Adherence — 94.8; 82.8 percentage of doses taken
Depression
Primary: Medication Adherence, as Measured by Electronic Pill Container — 58.76; 34.7 Percentage of Days — p=<.05
Medication Adherence · Mobile Application
Primary: Usability of the SAM App — 1.14; 1.32; 1.35; 1.81 score on a scale
Bipolar Disorder
Primary: Change in Treatment Adherence Within the Past Month as Measured by the Tablet Routines Questionnaire — -27.8 units on a scale — p=<.001
Hypertension
Primary: Systolic Blood Pressure — 134.5; 141.7; 134.6 mm Hg
Adherence
Primary: Medication Adherence - Pill Count — 0.46; 0.53 Probability of adherence (PT/PP => 0.8) — p=0.04
Diabetes Mellitus · Medication Adherence
Primary: Change in Self Reported Medication Adherence — 0.78; 0.74; 0.53; 0.62 Scores on a scale — p=0.22
Attention Deficit Hyperactivity Disorder
Primary: Proportion of Days Covered With Medicine — 0.69 Proportion of days covered with medicine
Systemic Lupus Erythematosus
Primary: Feasibility as Measured by Number of Participants With EMR (Electronic Medical Record) Documentation of Adherence — 116 Participants
Bipolar Disorder
Primary: Change in Treatment Non-adherence as Measured by the Tablets Routine Questionnaire (TRQ) (Past Month) — -23.6 percentage of medication not taken — p=<0.001
Bipolar Disorder
Primary: Change From Baseline in the Tablet Routine Questionaire (TRQ) "Past Month" Item at 24 Weeks — 21.5; 28.0 percent of medications not taken
Medication Adherence · Kidney Transplantation
Primary: Change in Number of Patients Being Adherent/Non-aherent After the Intervention — 15; 30; 34; 35 Participants
Acute Coronary Syndrome (ACS)
Primary: Adherence to Refills and Medications Scale (ARMS) — 12.03; 12.18 units on a scale
Atrial Fibrillation · Medication Adherence
Primary: Medication Adherence — 93.08; 89.52 percentage of doses recorded as taken — p=0.28
Type 2 Diabetes · Mild Cognitive Impairment
Primary: Percent of Participants With Improvement in Hemoglobin A1c by 0.5%" — 25; 22 Participants — p=0.31